If you've been diagnosed with sleep apnea, you likely already know that a continuous positive airway pressure (CPAP) device ...

A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate ...

Obstructive sleep apnea occurs when the upper airway repeatedly collapses during sleep, temporarily blocking airflow ...

Sleep apnea is a common sleep disorder that affects more than 20 percent of people in the United States. It happens when your breathing temporarily stops while you sleep. Depending on the severity of ...

A European clinical trial finds the drug sulthiame can cut breathing interruptions in sleep apnea, offering hope for a ...

Sleep apnea is a common sleep disorder that affects more than 20 percent of people in the United States. It happens when your breathing temporarily stops while you sleep. Depending on the severity of ...

A once-daily pill called sulthiame cut breathing interruptions during sleep by up to 47 percent in adults with obstructive ...

Mouth taping aims to encourage nasal breathing by taping your mouth shut during sleep, but evidence on this practice is anecdotal and clinical studies are lacking. Nasal breathing can humidify air, ...

Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...

Last week, Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep. The ...

Sleep apnea, a sleep disorder typically managed with a medical device that aids in breathing, now has its first FDA-approved drug therapy, an Eli Lilly medicine initially developed as a treatment for ...

Sulthiame, which has been used as an anticonvulsant, helps to stabilise brain respiratory signals and boosts upper airway ...